EP
BVS icon

Essential Partners’s Bioventus BVS Stock Holding History

Essential Partners’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.45K Sell
365
-180
-33% -$1.72K ﹤0.01% 1720
2026
Q1 		$4.98K Hold
545
– – ﹤0.01% 1574
2025
Q4 		$4.05K Buy
545
+12
+2% +$86 ﹤0.01% 1514
2025
Q3 		$3.57K Buy
533
+206
+63% +$1.43K ﹤0.01% 1559
2025
Q2 		$2.17K Buy
+327
New +$2.32K ﹤0.01% 1296

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Essential Partners's BVS Position: Q2 2026 in Review

Essential Partners reduced its Bioventus (BVS) stake by 33% in Q2 2026, selling an estimated $1.72K and leaving 365 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Essential Partners first reported a position in BVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.98K in Q1 2026. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Essential Partners held 365 shares of Bioventus worth $3.45K as of Q2 2026.
  • Essential Partners sold 180 Bioventus shares in Q2 2026, an estimated $1.72K.
  • Bioventus made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1720 holding.
  • Essential Partners first reported a position in Bioventus in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Bioventus position peaked at $4.98K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.